
Evogene Ltd. (($EVGN)) has held its Q3 earnings call. Read on for the main highlights of the call. Evogene’s earnings call offered a mixed picture. Management highlighted meaningful progress in
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| EVGN | Evogene | 0.32 | -0.81 | -72.04% |
| Name | Price | % Change | |
|---|---|---|---|
| $0.32 | -72.04% |

Evogene Ltd. (($EVGN)) has held its Q3 earnings call. Read on for the main highlights of the call. Evogene’s earnings call offered a mixed picture. Management highlighted meaningful progress in

Evogene Ltd. (($EVGN)) has held its Q3 earnings call. Read on for the main highlights of the call. Evogene’s earnings call presented a mixed picture. The company reported scientific progress

Evogene ( ($EVGN) ) has issued an announcement. Evogene is a computational chemistry company that uses proprietary AI-driven technologies to design and develop novel small molecules for pharmaceutical and agricultural

Evogene ( ($EVGN) ) just unveiled an update. Evogene reported management changes, including the appointment of Dr. Adi Zuluf-Shani as chairperson of its board on November 18, 2026. VP Finance

Evogene Ltd. (EVGN) is scheduled to report 3rd quarter earnings on 11/18/2026, before the market opens. Regarding Q3 estimates, Wall Street analysts expect Evogene Ltd. to post earnings of -$0.19

Evogene ( ($EVGN) ) just unveiled an announcement. Evogene Ltd. held a special general meeting of shareholders on November 10, 2026, at its offices. Shareholders approved Proposals Nos. 1-3, and

An update from Evogene ( ($EVGN) ) is now available. On October 28, 2026, Evogene announced that acute graft-versus-host disease (aGVHD) will be the target indication for its internal AI-driven

The latest update is out from Evogene ( ($EVGN) ). On October 6, 2026, Evogene entered into a cooperation agreement with L.I.A. Pure Capital and Invest Pro Shukai Hon to

Evogene (EVGN) announced that it has entered into a comprehensive cooperation agreement with L.I.A. Pure Capital and Invest Pro Shukai Hon, together, the “Pure Capital Group”, to resolve all outstanding

Evogene ( ($EVGN) ) has issued an update. On September 30, 2026, Evogene reported it had received a letter from Nasdaq granting an additional 180-day grace period, until March 29,
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| buy | Reiterated | May 26, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Mar 11, 2027TBA | $5.65M | $-0.20 | $390.00K | 0.02 | -0.19 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.